TradingView
RocketTickers
1 de Nov. de 2018 17:31

AbbVie Announces Positive Results from CLL14 Largo

NYSE:ABBV1D
AbbVie Inc.NYSE

Descripción

⋅
ABBV: AbbVie
2018-10-31 16:14:00
AbbVie Announces Positive Results from CLL14, a Phase 3 Trial Evaluating a Venetoclax Combination as First-Line Therapy with a Fixed Duration of Treatment in Patients with Chronic Lymphocytic Leukemia
Beyond Technical Analysis
Más